FIMECS
FIMECS is a protein degradation technology-based drug discovery biotech focused on developing first-in-class protein degradation therapeutics for cancers and other difficult-to-treat diseases. The human body is comprised of at least 18,097 proteins.It has been revealed that 1,500 of them are related to certain diseases, nevertheless only about 300 proteins have been regarded as druggable targets by small molecule drug discovery and all the rest have been undruggable.
FIMECS
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2018-01-18
Address:
Fujisawa, Kanagawa, Japan
Country:
Japan
Website Url:
http://www.fimecs.com
Total Employee:
1+
Status:
Active
Contact:
+81-466-32-1169
Total Funding:
810 M JPY
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Wordpress Plugins Nginx Microsoft Exchange Online
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Current Employees Featured
Yusuke Tominari Representative Director, CEO, CSO, and Founder @ Fimecs
Representative Director, CEO, CSO, and Founder
Founder
Investors List
ANRI
ANRI investment in Series A - Fimecs
UTokyo Innovation Platform
UTokyo Innovation Platform investment in Series A - Fimecs
Kyoto University Innovation Capital
Kyoto University Innovation Capital investment in Series A - Fimecs
Cosmo Bio
Cosmo Bio investment in Seed Round - Fimecs
Takeda
Takeda investment in Seed Round - Fimecs
Official Site Inspections
http://www.fimecs.com
- Host name: sv5145.xserver.jp
- IP address: 202.254.236.146
- Location: Japan
- Latitude: 35.69
- Longitude: 139.69
- Timezone: Asia/Tokyo
More informations about "Fimecs"
About | FIMECS, Inc.
Dec 31, 2023 FIMECS, Inc. Address: 26-1, Muraoka-Higashi 2-Chome, Fujisawa, Kanagawa 251-0012, JapanMap TEL: +81-466-96-0261: Establishment: Jan. 18th, 2018: CEO: Yusuke …See details»
創薬で新しい未来をつくるファイメクス株式会社
ファイメクス株式会社 (FIMECS, Inc.) 〒251-0012 神奈川県藤沢市村岡東二丁目26番地の1 TEL : 0466-96-0261. Follow Us.See details»
About us | FIMECS, Inc.
FIMECS, Inc. 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, Japan On the premises of Shonan Health Innovation Park. Follow Us. Contact; Recruit; Privacy policySee details»
Fimecs - Crunchbase Company Profile & Funding
FIMECS is a protein degradation technology-based drug discovery biotech focused on developing first-in-class protein degradation therapeutics for cancers and other difficult-to-treat diseases. …See details»
FIMECS, Inc. - LinkedIn
FIMECS, Inc. today annouces that Kanae Gamo, CSO of FIMECS is awareded ｢Women In Tech 30 2024｣ organized by Forbes JAPAN.It is one of the features in the September 25 issue of Forbes JAPAN ...See details»
FIMECS Inc. - Devex
FIMECS is a protein degradation technology-based drug discovery biotech focused on developing first-in-class protein degradation therapeutics for cancers and other difficult-to-treat diseases.See details»
FIMECS, INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for FIMECS, INC. of FUJISAWA, KANAGAWA. Get the latest business insights from Dun & Bradstreet.See details»
Fimecs - Products, Competitors, Financials, Employees, …
Fimecs is a biopharmaceutical venture focused on the research and development of new drugs based on targeted protein degradation within the pharmaceutical industry. Use the CB Insights …See details»
Acquisition of FIMECS by RaQualia Pharma
FIMECS, Inc. is developing a new class of drugs based on targeted protein degradation for the currently ‘undruggable’ targets in immuno-oncology and oncology areas. The company …See details»
FIMECS, Inc.
Mar.31,2023 News release FIMECS Appoints Mr. Masanobu Yatabe as Chief Financial Officer 2.24 KB Mar.28,2023 News release FIMECS Organizes 2nd Targeted Protein Degradation …See details»
FIMECS, Inc., a startup utilizing Kyoto University’s research ...
Dec 23, 2022 FIMECS, Inc. finished in the 2nd place. Given the current status of more Japanese start-ups being expected, but yet to go global, the FIMECS’s runner-up position at the final …See details»
Fimecs Company Profile 2024: Valuation, Funding & Investors
Fimecs has raised $26.1M. Who are Fimecs’s investors? Nissay Capital , New Energy and Industrial Technology Development Organization, ANRI , Kyoto University Innovation Capital , …See details»
Fimecs - Funding, Financials, Valuation & Investors - Crunchbase
FIMECS is a drug discovery company that develops protein degradation therapeutics for cancers and difficult-to-treat diseases. Search Crunchbase. ... How much funding has this organization …See details»
FIMECS, Inc. | Portfolio | UTokyoIPC - FIMECS, Inc. - 東大IPC− ...
FIMECS is a protein degradation technology-based drug discovery biotech focused on developing first-in-class protein degradation therapeutics for cancers and other difficult-to-treat diseases. …See details»
Leadership｜FIMECS, Inc.
Yusuke Tominari is responsible for the overall success of a business entity or other organization and for making top-level managerial decisions as a CEO. He launched FIMECS with his …See details»
FIMECS Inc - VentureRadar
"Fymex is a pioneering drug discovery venture focused on developing novel drugs through protein degradation mechanisms. Leveraging its proprietary E3 ligase binding molecules and the …See details»
2nd Targeted Protein Degradation Conference in Japan
Jul 27, 2023 Jose S. Santos, Ph.D. has served as a Senior Director in Early Discovery at Nurix since June 2022. Since joining Nurix in 2018, Jose has focused on establishing the company’s …See details»
Corporate Philosophy | FIMECS, Inc.
Vision. New Medicine, New Hope, New Era. To create medicines that once didn’t exist, offering new hope to the world. To make people who had thought of giving up, smile with hope.See details»
FIMECS, Inc. Concludes Licensing Agreement with Takeda to …
Apr 13, 2018 KANAGAWA, Japan—(BUSINESS WIRE)—FIMECS, Inc. (“FIMECS”), a private biotechnology company creating a new class of drugs based on protein degradation, today …See details»
Sustainability | FIMECS, Inc.
In addition, we will enhance our flexible work system and leave system to enable talented employees to fully demonstrate their abilities, as well as promote diversity and inclusion to …See details»